214 related articles for article (PubMed ID: 1900481)
1. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate.
Schoolcraft W; Sinton E; Schlenker T; Huynh D; Hamilton F; Meldrum DR
Fertil Steril; 1991 Mar; 55(3):563-6. PubMed ID: 1900481
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
[TBL] [Abstract][Full Text] [Related]
3. Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle.
Hofmann GE; Bergh PA; Guzman I; Masuku S; Navot D
Hum Reprod; 1993 May; 8(5):695-8. PubMed ID: 8314961
[TBL] [Abstract][Full Text] [Related]
4. Progesterone response to exogenous gonadotropins after suppression with leuprolide acetate in gamete intrafallopian transfer.
Riemann DC; Schoolcraft WB; Sinton EB
J Reprod Med; 1991 Mar; 36(3):190-4. PubMed ID: 1903164
[TBL] [Abstract][Full Text] [Related]
5. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
[TBL] [Abstract][Full Text] [Related]
6. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
Garcia JE; Padilla SL; Bayati J; Baramki TA
Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
[TBL] [Abstract][Full Text] [Related]
7. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization.
Tsai HD; Chen CM; Lo HY; Chang CC
Hum Reprod; 1995 Nov; 10(11):2909-12. PubMed ID: 8747042
[TBL] [Abstract][Full Text] [Related]
9. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome.
Edelstein MC; Seltman HJ; Cox BJ; Robinson SM; Shaw RA; Muasher SJ
Fertil Steril; 1990 Nov; 54(5):853-7. PubMed ID: 2121554
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hCG versus GnRH analog for releasing oocytes following ultra low-dose gonadotropin stimulation.
Check JH; Vetter BH; Weiss W
Gynecol Endocrinol; 1993 Jun; 7(2):115-22. PubMed ID: 8213225
[TBL] [Abstract][Full Text] [Related]
11. Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval.
Cedars MI; Surey E; Hamilton F; Lapolt P; Meldrum DR
Fertil Steril; 1990 Apr; 53(4):627-31. PubMed ID: 2108057
[TBL] [Abstract][Full Text] [Related]
12. Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix.
Tavaniotou A; Albano C; Smitz J; Devroey P
Hum Reprod; 2001 Apr; 16(4):663-7. PubMed ID: 11278214
[TBL] [Abstract][Full Text] [Related]
13. Induction of ovulation with luprolide acetate and human menopausal gonadotropin.
Lewinthal D; Taylor PJ; Pattinson HA; Corenblum B
Fertil Steril; 1988 Apr; 49(4):585-8. PubMed ID: 3127242
[TBL] [Abstract][Full Text] [Related]
14. Elevated luteinizing hormone on the day of human chorionic gonadotropin administration does not reduce cycle fecundity in a low-dose flare-up in vitro fertilization protocol.
Lincoln SR; Long CA; Whitworth NS; Sopelak VM; Cowan BD
Fertil Steril; 1995 Mar; 63(3):563-5. PubMed ID: 7851587
[TBL] [Abstract][Full Text] [Related]
15. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
16. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins.
Silverberg KM; Burns WN; Olive DL; Riehl RM; Schenken RS
J Clin Endocrinol Metab; 1991 Oct; 73(4):797-803. PubMed ID: 1909704
[TBL] [Abstract][Full Text] [Related]
17. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
Claman P; Domingo M; Leader A
Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
[TBL] [Abstract][Full Text] [Related]
18. Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients.
Edelstein MC; Brzyski RG; Jones GS; Oehninger S; Sieg SM; Muasher SJ
J In Vitro Fert Embryo Transf; 1990 Jun; 7(3):172-6. PubMed ID: 2116488
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of short pituitary suppression with gonadotropin-releasing hormone agonist leuprolide during induction of ovulation for in vitro fertilization.
Henig I; Chan PJ; Prough SG; Tredway DR
J In Vitro Fert Embryo Transf; 1989 Aug; 6(4):195-200. PubMed ID: 2515234
[TBL] [Abstract][Full Text] [Related]
20. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
